Organization | Smiths Medical, ASD, Inc.

Smiths Medical, ASD, Inc. Report issue

For profit Phase 2 Phase 3 Phase 4

Founded: Dublin OH United States (1940)

Status: Acquired by ICU Medical Inc (2021)

Organization Overview

First Clinical Trial

2015

NCT02539628

First Marketed Drug

2014

naltrexone (revia)

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Historical Acquisition Tree

Active Ingredients

Key: Smiths Medical, ASD, Inc. (0) Acquired (1)

Key: Smiths Medical, ASD, Inc. (0) Acquired (1)

Indications